3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection
Egile Nagusiak: | , , , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Nature Publishing Group
2022-03-01
|
Saila: | Signal Transduction and Targeted Therapy |
Sarrera elektronikoa: | https://doi.org/10.1038/s41392-022-00937-9 |